Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

Human Immunodeficiency Virus (HIV) Infection Clinical Trial

Official title:
An Open-Label, Parallel Group, Single And Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

Status Completed

Clinical Trial Summary

The purpose of this study is to assess whether a dosing adjustment is needed in patients with renal impairment.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Acquired Immunodeficiency Syndrome
HIV Infections
Human Immunodeficiency Virus (HIV) Infection
Immunologic Deficiency Syndromes

Clinical Trial Details

NCT number	NCT00717067
Study type	Interventional
Source	ViiV Healthcare
Contact
Status	Completed
Phase	Phase 4
Start date	July 2008
Completion date	November 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02715700` - Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)	Phase 1
Completed	`NCT03667547` - Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)	Phase 4
Completed	`NCT01422330` - A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients	Phase 4
Active, not recruiting	`NCT05452616` - Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis	N/A
Completed	`NCT04515641` - Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)	Phase 1
Terminated	`NCT02818283` - Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention	N/A
Completed	`NCT04303156` - Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)	Phase 1
Recruiting	`NCT04375800` - Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)	Phase 2
Completed	`NCT00821535` - Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers	Phase 1
Completed	`NCT03618511` - Interventions to Improve HIV Antiretroviral Therapy Adherence	N/A
Completed	`NCT01768182` - Folinic Acid and Vascular Reactivity in HIV	N/A